Scienture Holdings, Inc. has entered into a securities purchase agreement with institutional investors to purchase 3,225,000 shares of common stock at $1.20 per share in a registered direct offering.
The gross proceeds for the offering are expected to be approximately $3.9 million before deducting expenses.
The offering is expected to close on August 15, 2025, subject to customary closing conditions.
Offering Details
3,225,000 shares of common stock at $1.20 per share
Gross Proceeds
Approximately $3.9 million before deductions
Closing Date
Expected on August 15, 2025
- The offering provides a significant influx of capital for Scienture Holdings, Inc.
- This strategic move through institutional investors showcases confidence in the company's future prospects.
The securities purchase agreement and direct offering represent a key step in the financial growth of Scienture Holdings, Inc., reinforcing its commitment to enhancing value for patients and caregivers.